Professor of Oncology and Immunology, University of Washington; Investigator, Parker Institute for Cancer Immunotherapy, Fred Hutchinson Cancer Research Center
Immunology, Immuno-oncology, Cancer Biology, Genetic Engineering, Cell Therapy
EDUCATION
BA - Washington University, St. Louis
MD - State University of New York
Residency - University of California, San Diego
Postdoctoral Fellow - University of California, San Diego
AWARDS AND ACCOLADES
American Society of Clinical Investigation Fellow
Association of American Physicians Fellow, 1998
American Association for the Advancement of Science Fellow, 2007
Cancer Research Institute’s William B. Coley Award for Distinguished Research in Tumor Immunology, 2011
Society for Immunotherapy of Cancer Richard Smalley Memorial Award, 2018
Fellow of the American Association for Cancer Research Academy, 2019
Distinguished Fellow of the American Association of Immunologists, 2019
American Society of Hematology E. Donnall Thomas Prize for Pioneering Research Achievements in Hematology, 2019
Precision Medicine World Conference (PMWC) Luminary Award, 2020
COMPANIES AND BOARDS
Co-Founder: Targeted Genetics (NASDAQ: TGEN), Juno Therapeutics (acquired by Celgene), Affini-T Therapeutics
Board of Directors: Nestle SA, Vilcek Foundation
Scientific Advisory Board: Celsius Therapeutics, Earli, Immunoscpate, Metagenomi, Elpiscience Biopharma